ASP Isotopes Inc. has acquired Renergen, a South African helium company, for $161.8 million, enhancing its access to high-grade helium reserves and ensuring a stable supply amidst global shortages.

Information on the Target

A SP Isotopes Inc. (ASPI) has officially announced its acquisition of Renergen, a prominent South African company renowned for its substantial helium reserves. The acquisition, valued at $161.8 million, will provide ASPI with direct access to one of the highest-grade helium reserves globally, located in the Virginia Gas Project, where helium concentrations can reach up to 12%, significantly surpassing the global average of approximately 0.5%.

This strategic acquisition not only allows ASPI to expand its portfolio but also positions it to address the escalating global demand for helium, a vital non-renewable resource that is critical across various industries, including healthcare, semiconductor manufacturing, and aerospace.

Industry Overview in South Africa

The helium industry in South Africa is at a pivotal point, primarily due to the global decline in helium supply from traditional sources. As countries like the U.S. wind down their Federal Helium Reserve, South Africa

View Source

ASP Isotopes

invested in

Renergen

in 2025

in a Other deal

Disclosed details

Transaction Size: $162M

EBITDA: $300M

Enterprise Value: $162M

Equity Value: $107M


Multiples

EV/EBITDA: 0.5x

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert